tiprankstipranks

Beth Hecht Insider Profile

11 Followers
Beth Hecht, Director at Neos Therapeutics, holds 1.55M shares in Xeris Pharmaceuticals (Ticker: XERS), holds 18.84K shares in Iterum Therapeutics (Ticker: ITRM), holds 9.05K shares in Aytu BioScience (Ticker: AYTU).
tipranks
Beth Hecht

Beth Hecht
Neos Therapeutics (NEOS)
Director

Ranked #14,666 out of 98,624 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+59.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
98.12%
0.97%
0.91%
A breakdown of Beth Hecht's holdings

Insider Roles

Xeris Pharmaceuticals
(XERS)
CLO and Corporate Secretary
Iterum Therapeutics
(ITRM)
Director
Aytu BioScience
(AYTU)
Director
Roles that Beth Hecht holds in companies

Most Profitable Insider Trade

Stock:
Xeris Pharmaceuticals
(XERS)
Rating:Informative Buy
Date:Mar 16, 2020 - Mar 16, 2021
Return:+200.00%
The most profitable trade made by Beth Hecht

Beth Hecht's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NEOS
Neos Therapeutics
Mar 19, 2021
Uninformative Sell
$0.00
Xeris Pharmaceuticals
Jan 31, 2024
CLO and Corporate Secretary
Uninformative Buy
$2.94M
Iterum Therapeutics
Jun 15, 2023
Director
Uninformative Buy
$29.20K
Aytu BioScience
Apr 12, 2021
Director
Uninformative Buy
$27.25K
List of latest transactions for each holding click on a transaction to see Beth Hecht's performance on stock

Beth Hecht insider profile FAQ

What is the percentage of profitable transactions made by Beth Hecht?
The percentage of profitable transactions made by Beth Hecht is 67%.
    What is the average return per transaction made by Beth Hecht?
    The average return per transaction made by Beth Hecht is 59.50%.
      What stocks does Beth Hecht hold?
      Beth Hecht holds: NEOS, XERS, ITRM, AYTU stocks.
        What was Beth Hecht’s latest transaction?
        Beth Hecht latest transaction was an Uninformative Buy of ―.
          What was Beth Hecht's most profitable transaction?
          Beth Hecht’s most profitable transaction was an Informative Buy of XERS stock on March 16, 2020. The return on the trade was 200.00%.
            What is Beth Hecht's role in Neos Therapeutics?
            Beth Hecht's role in Neos Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.